---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Anti-infective Guidelines"
developer_entity: "MUMS Health"
bundle_id: "com.mumshealth.antiinfective"
app_store_id: "992143323"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Paid"
offline_capable: true
market_region: "US"
platforms: "iOS"
app_last_updated: "2019-09-12"
report_date: "2026-08-10"
last_verified: "2026-08-10T00:00:00.000Z"
report_version: "1.1"
total_reviews: 0
confidence: "medium"
confidence_score: 0.45
data_age_days: 51
momentum_velocity: "zombie"
intelligence_version: 6
nemesis: "Edenred Wallet"
competitor_count: 11
tags: ["medical", "paid", "mobile app", "app review", "app analysis", "family", "medicine", "practitioners"]
canonical_url: "https://marlvel.ai/apps/com-mumshealth-antiinfective"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# Anti-infective Guidelines Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Paid

> **TL;DR:** Anti-infective Guidelines is a medical app by MUMS Health, available on iOS.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Anti-infective Guidelines is a medical app by MUMS Health.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Category** | Medical |
| **Developer** | MUMS Health |
| **Pricing** | Paid |
| **Platforms** | iOS |
| **Confidence** | Medium (0.45/1.0) |
| **Data Age** | 51d |

## Metadata & Market Performance
- **Publisher:** MUMS Health
- **Category:** Medical
- **Target Audience:** Family medicine practitioners and emergency room staff requiring evidence-based, offline-accessible antibiotic guidelines.
- **Platforms:** iOS
- **Version Reviewed:** 1.1
- **Report Date:** 2026-08-10
- **Signal Count:** 38 reviews analyzed
- **Confidence:** Medium (0.45/1.0)
- **App Store ID (iOS):** 992143323
- **Bundle ID:** com.mumshealth.antiinfective
- **Performance Trend:** Declining
- **Data Window:** Analysis based on signals collected up to 2026-08-10

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Anti-infective Guidelines is a medical reference app for family medicine and ER staff, providing offline antibiotic prescription tools on iOS.
**Why users hire it:** Clinicians hire this tool for immediate, offline access to evidence-based guidelines, reducing the risk of unnecessary antibiotic exposure in high-pressure environments.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Clinical Decision Tools:** Interactive logic flows for antibiotic prescription guidance; justifies the $17.99 price point.
- **[Standard] Offline Access:** Full content availability without internet; ensures reliability in hospital settings with poor connectivity.
  * *User Intent:* Users want uninterrupted access without internet dependency.
- **[Differentiator] Print Material Discount:** Access to discounted physical viral info pads via the website; cross-sells physical products to increase customer lifetime value.
  * *User Intent:* Users value self-expression and personalized experiences.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

The app occupies a niche medical reference space, currently ranking in the top 100 paid medical category across multiple markets including GB and SA. The lack of updates since 2019 relative to category norms signals a high risk of churn as clinical standards evolve.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Paid
- **Tiers:** One-time purchase at $17.99
- **Price:** iOS: $17.99
- **Analysis:** Paid model at $17.99 per download, with proceeds explicitly allocated to maintaining editorial independence.

<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Offline-first architecture ensures utility in hospital environments with poor connectivity

**Growth Levers:**
- Integrate digital CME tracking to align with the PAACT program and drive recurring professional engagement


<!-- /section:swot -->
## Recent Changes (v5 → v6) {#recent-changes}

The analysis shifted from a general critique of development inactivity to a specific recommendation for a subscription-based business model to address the clinical trust deficit.

**Overall trend**: Declining
**Compared at**: 2026-08-10

### High-impact changes
- **[Shifted] Strategic Pivot to Subscription** (pricing)

### Medium-impact changes
- **[] Consolidation of Clinical Trust Risks** (swot)
- **[] Refined Competitive Positioning** (positioning)

<!-- section:rivals -->
## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### Anti-infective Guidelines vs Edenred Wallet
- **[Edenred Wallet](https://marlvel.ai/apps/edenred-wallet)** by Edenred: While in a different category, Edenred competes for the same professional user's mobile real estate by offering high-frequency utility and financial management tools that distract from clinical reference apps.
  - **Key differences:**
    - Offers dynamic CVV and card toggles for security, whereas target lacks any transactional financial features.
    - Provides an integrated affiliate map for physical locations, while target is purely a static content reference.
    - Maintains massive user scale and daily engagement, dwarfing target's niche medical professional user base.

### Contenders (Strong Challengers)
- **[Zurich Mobil](https://marlvel.ai/apps/zurich-mobil)** by Zurich Yasam ve Emeklilik A.S.: Zurich Mobil competes for the professional's digital wallet space, offering pension and fund management that requires frequent user interaction.
  - Integrates biometric authentication for secure access, a feature this app lacks for its content.
  - Provides unique gift pension and fund integration features that create a distinct financial ecosystem.
- **[HSA Bank](https://marlvel.ai/apps/hsa-bank)** by Webster Bank®: HSA Bank competes by managing the financial side of healthcare, creating a secondary touchpoint for the same medical professionals who use this app.
  - Enables direct reimbursement and claims filing, bridging the gap between clinical care and financial administration.
  - Features a contribution planner and investment management tools that provide long-term financial utility for users.
- **[כלל ביטוח ופיננסים](https://marlvel.ai/apps/nineoneone911)** by Clal Insurance: This app competes for the attention of busy professionals by bundling insurance and financial management into a single, high-utility interface.
  - Includes a financial dashboard and quick pay features that provide immediate value beyond simple information.
  - Offers specialized travel insurance management tools that target lacks entirely in its medical-only focus.
- **[FlexFacts Participant Mobile](https://marlvel.ai/apps/flexfacts-participant-mobile)** by WealthCareMobile: This app directly overlaps with the medical professional audience by managing benefits and healthcare accounts, creating a competing workflow for medical administrative tasks.
  - Focuses on benefit administration and account management, which complements the clinical data found in this app.
  - Provides a dedicated mobile interface for claims, which is a high-value utility for medical professionals.

### Peers (What They Do Better)
- **[PeiGo: tu dinero en una app](https://marlvel.ai/apps/ec-com-peigo)** by PeiGo: PeiGo competes by offering a streamlined financial experience that prioritizes ease of use, similar to this app's goal of quick clinical navigation.
  - Provides a physical Mastercard debit card integration that bridges digital and real-world financial utility.
  - Features automated top-ups and expense control tools that simplify personal financial management for users.
- **[Manjushree Smart](https://marlvel.ai/apps/com-f1soft-manjushreefinance)** by F1soft: This app competes for the same mobile screen time by providing essential financial services and security infrastructure to professional users.
  - Includes robust fund transfer and QR payment capabilities that drive high daily active usage.
  - Features advanced security infrastructure that provides a safer environment for sensitive financial data.
- **[VOOMA](https://marlvel.ai/apps/com-kcbbankgroup-vooma-android)** by KCB BANK GROUP: VOOMA competes by offering digital wallet and payment services that capture the professional's daily financial workflow.
  - Offers comprehensive digital payment solutions that turn the app into a primary financial utility.
  - Provides integrated wallet services that simplify daily transactions for busy professional users.
- **[Subspace: Subscriptions](https://marlvel.ai/apps/subspace-subscriptions)** by Nilesh Kumar: Subspace competes for the user's attention by managing recurring expenses, a common pain point for the same professional demographic.
  - Allows for subscription sharing and discounted gift cards, creating a unique value-add for cost-conscious users.
  - Includes bill payment features that consolidate multiple financial obligations into one single mobile interface.

### New Kids on the Block (What's Innovative)
- **[FPay](https://marlvel.ai/apps/fpay)** by Ficoven Investments Limited: Users report: FPay is a new entrant in the financial space that could divert user attention through its focus on real-time fraud monitoring and KYC.
  - Implements real-time fraud monitoring, which provides a high level of security for new financial users.
- **[Malloy Banks](https://marlvel.ai/apps/malloy-banks)** by WealthCareMobile: Malloy Banks is a new entrant targeting the administrative side of professional life, potentially competing for the same user base as FlexFacts.
  - Focuses on streamlined claim submission, which simplifies the administrative burden for busy professional users.

<!-- /section:rivals -->
<!-- section:whats-new -->
## What's New

- **Latest (v1.0.1, 8 years ago):** Addressed minor bugs.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- Quiet 8 years, no major features.
- Last release 2019.

> **Cadence:** 4 total versions · 0 majors in last 6 months · 78 days since last update · 1011 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Anti-infective Guidelines is a medical app that is a paid app.

<!-- speakable-start -->
> **Bottom Line:** Anti-infective Guidelines provides a specialized, offline-first clinical utility, but the 2500+ day update gap compromises its value as a medical reference, so the developer must pivot to a subscription model that funds regular evidence-based content refreshes.
<!-- speakable-end -->

**Best for:** Family medicine practitioners and emergency room staff requiring evidence-based, offline-accessible antibiotic guidelines.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [PIVOT] Pivot to subscription model because static paid content lacks update funding → enable regular evidence-based refreshes
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors


- Biometric authentication (available in Zurich Mobil but missing here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Declining

The medical reference market is shifting toward dynamic, cloud-connected tools that integrate with hospital administrative workflows. Anti-infective Guidelines remains in maintenance mode, which leaves it exposed to competitors that offer real-time evidence updates and biometric security.

- 🔴 The 8-year update gap (last release 2019) creates a clinical trust deficit, which will accelerate user churn to modern, frequently updated medical references.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Total Reviews | 0 |
| Confidence | Medium |
| Pricing Model | Paid |
| Platforms | iOS |
| Key Features | 3 analyzed |
| Trend | Declining |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Anti-infective Guidelines** (this app) | N/A/5 | N/A | MUMS Health |
| [כלל ביטוח ופיננסים](https://marlvel.ai/apps/nineoneone911) | 3.7/5 | N/A | Clal Insurance |
| [PeiGo: tu dinero en una app](https://marlvel.ai/apps/ec-com-peigo) | 4.2/5 | N/A | PeiGo |
| [VOOMA](https://marlvel.ai/apps/com-kcbbankgroup-vooma-android) | 4.0/5 | N/A | KCB BANK GROUP |
| [Manjushree Smart](https://marlvel.ai/apps/com-f1soft-manjushreefinance) | 4.2/5 | N/A | F1soft |
| [FlexFacts Participant Mobile](https://marlvel.ai/apps/flexfacts-participant-mobile) | 4.1/5 | Mixed | WealthCareMobile |

## Company Profile
- **Developer:** MUMS Health
- **Website:** [https://mumshealth.com](https://mumshealth.com)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/anti-infective-guidelines/id992143323?uo=2)
- **Dev Site:** [Official Website](https://mumshealth.com)
- **Sources:** Developer website content, About us / company information, App store metadata.

## Related Intel Reports
- [*כלל ביטוח ופיננסים*](https://marlvel.ai/apps/nineoneone911) (Clal Insurance) · 3.7/5 Rating
- [*PeiGo: tu dinero en una app*](https://marlvel.ai/apps/ec-com-peigo) (PeiGo) · 4.2/5 Rating
- [*VOOMA*](https://marlvel.ai/apps/com-kcbbankgroup-vooma-android) (KCB BANK GROUP) · 4.0/5 Rating
- [*Manjushree Smart*](https://marlvel.ai/apps/com-f1soft-manjushreefinance) (F1soft) · 4.2/5 Rating
- [*FlexFacts Participant Mobile*](https://marlvel.ai/apps/flexfacts-participant-mobile) (WealthCareMobile) · 4.1/5 Rating
- [*Malloy Banks*](https://marlvel.ai/apps/malloy-banks) (WealthCareMobile) · N/A Rating
- [*Zurich Mobil*](https://marlvel.ai/apps/zurich-mobil) (Zurich Yasam ve Emeklilik A.S.) · 4.5/5 Rating
- [*Subspace: Subscriptions*](https://marlvel.ai/apps/subspace-subscriptions) (Nilesh Kumar) · 3.5/5 Rating
- [*Edenred Wallet*](https://marlvel.ai/apps/edenred-wallet) (Edenred) · 4.7/5 Rating
- [*FPay*](https://marlvel.ai/apps/fpay) (Ficoven Investments Limited) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.45/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 38
- **Data Sources:** developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 51 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/com-mumshealth-antiinfective)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.